4.7 Article

Bioengineered Kidney Tubules Efficiently Clear Uremic Toxins in Experimental Dialysis Conditions

Journal

Publisher

MDPI
DOI: 10.3390/ijms241512435

Keywords

bioartificial kidney; dialysis fluid; uremic plasma; uremic toxins; proximal tubule epithelial cells

Ask authors/readers for more resources

Patients with end-stage kidney disease suffer from high levels of protein-bound uremic toxins. Conventional dialysis methods are ineffective in removing these toxins. A potential solution could be a bioartificial kidney composed of membranes with proximal tubule epithelial cells that actively secrete these toxins. However, the development of this bioartificial kidney is hampered by a lack of knowledge regarding the cytocompatibility of the dialysis fluid. This study shows that the dialysis fluid does not affect the viability or function of the cells, and efficiently clears the toxins from the perfusion fluid.
Patients with end-stage kidney disease (ESKD) suffer from high levels of protein-bound uremic toxins (PBUTs) that contribute to various comorbidities. Conventional dialysis methods are ineffective in removing these PBUTs. A potential solution could be offered by a bioartificial kidney (BAK) composed of porous membranes covered by proximal tubule epithelial cells (PTECs) that actively secrete PBUTs. However, BAK development is currently being hampered by a lack of knowledge regarding the cytocompatibility of the dialysis fluid (DF) that comes in contact with the PTECs. Here, we conducted a comprehensive functional assessment of the DF on human conditionally immortalized PTECs (ciPTECs) cultured as monolayers in well plates, on Transwell(& REG;) inserts, or on hollow fiber membranes (HFMs) that form functional units of a BAK. We evaluated cell viability markers, monolayer integrity, and PBUT clearance. Our results show that exposure to DF did not affect ciPTECs' viability, membrane integrity, or function. Seven anionic PBUTs were efficiently cleared from the perfusion fluid containing a PBUTs cocktail or uremic plasma, an effect which was enhanced in the presence of albumin. Overall, our findings support that the DF is cytocompatible and does not compromise ciPTECs function, paving the way for further advancements in BAK development and its potential clinical application.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available